Hosseinion Warren bought 6,024 shares of Veraxa Biotech AG at $1.67 for $10.1k on Sep 10, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Sep 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$10,060.08Shares × reported price
Shares traded
6,024Ordinary Shares
Price per share
$1.67Reported price. Read footnotes for ranges.
% of reported position traded
0.96%This security and ownership context
Holdings after
634,692Direct
Trade date
Sep 10, 2026Buy
Filed
Sep 29, 2026, 4:10 PM ET19-day reporting delay
Accession
0001829126-26-010557Code P · Transaction 230941
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 628,668 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 19 calendar days after the transaction date.

VRXA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VRXA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +17%1d ago +21%
Returns since7d −18%30d −25%90d180d1y

Footnotes in full

F1: The reported securities reflect the forfeiture of 71,332 Ordinary Shares of Veraxa Biotech AG (the "Company"), par value CHF 1/113.25, for no additional consideration, in connection with the Company's business combination consummated on June 10, 2026.